Greenovation is managed by Dr. Andreas Schaaf and Jörg Alexander Ronde, who have extensive scientific and business experience in biotechnology.
Dr. Andreas Schaaf, Managing Director / CSO
Andreas Schaaf holds a PhD in plant biotechnology. Before joining Greenovation as research scientist in 2009, he held positions at the University of Muenster and Freiburg. At Greenovation, Andreas was responsible for advancing BryoTechnology to a fully viable biopharmaceutical platform. Andreas has been Chief Scientific Officer since 2015 and was appointed Managing Director at the end of 2019.